FinaXpress, an E. Coli platform for the expression of disulfide-bonded proteins - production of low-cost carrier proteins, vaccine antigens, and biotherapeutics

Authors

• Renaud Jacquemart, Fina Biosolutions, USAFollow
• Andrew Lees, Fina Biosolutions LLC, 9430 Key West Avenue, Suite 200, Rockville, MD, USA
• Natalia Oganesyan, Fina Biosolutions LLC, 9430 Key West Avenue, Suite 200, Rockville, MD, USA

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Renaud Jacquemart, Andrew Lees, and Natalia Oganesyan, "FinaXpress, an E. Coli platform for the expression of disulfide-bonded proteins - production of low-cost carrier proteins, vaccine antigens, and biotherapeutics" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/53